INVESTORS FAQs
     EMAIL ALERTS
     CONTACT US
SHAREHOLDER TOOLS
  • Briefcase
  • Printed Materials
  • Email Alerts
  • Download Center
  • snapshot
  • RSS
Stock Quote (NASDAQ: VRNM)
Price:
2.73
Change:
+ 0.19
Day High:
2.77
Day Low:
2.53
Volume:
52,400
3:59 PM ET on Jan 27, 2012
Delayed at least 20 minutes.
Provided by eSignal.
Investor Relations

Stock price graph
     
Verenium Corporation (Nasdaq: VRNM) is a pioneer in the development and commercialization of high-performance enzymes for use in industrial processes. Verenium currently sells enzymes developed using its R&D capabilities to industrial customers globally for use in markets including grain and oilseed processing, biofuels, animal health and nutrition and other specialty industrial processes. Verenium has built a world-class R&D organization renowned for its capabilities in the rapid screening, identification, evolution and bioengineering of novel enzymes that act as catalysts for biochemical reactions. The company harnesses the power of nature and uses its unique, patented technology to create products that transform industries by maximizing efficiency while improving environmental performance. For more information on Verenium, visit http://www.verenium.com.

View all »   RSSRecent Releases

Jan 23, 2012
First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration

Jan 5, 2012
Verenium Launches Second Enzyme Product for Oilfield Services

View all »Upcoming Events

There are currently no events scheduled.

  
    
 
FROM THE ENDS OF THE EARTH
TO THE EDGE OF TECHNOLOGY
CONTACT US | CAREERS | TERMS OF USE | SITE MAP
Verenium Corporation 2012